Using the in vitro drug sensitivity test to identify candidate treatments for transient abnormal myelopoiesis.
Yokosuka T, Ito M, Yoshino Y, Hirose A, Nakamura W, Sakurai Y, Hayashi A, Fujita S, Miyagawa N, Keino D, Iwasaki F, Hamanoue S, Yanagimachi M, Goto S, Nagai JI, Ueno H, Takita J, Tanaka Y, Taga T, Goto H.
Yokosuka T, et al. Among authors: hamanoue s.
Br J Haematol. 2022 Feb;196(3):764-768. doi: 10.1111/bjh.17970. Epub 2021 Nov 23.
Br J Haematol. 2022.
PMID: 34816427